NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 3 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Mphasis Q2 FY27 கான்கால்: Net New TCV $466M, வெற்றிகளில் AI ஒப்பந்தங்கள் 66%, வளர்ச்சி முன்னறிவிப்பு உயர்வு
Mphasis Q2 FY27 க்கான கான்கால் டிரான்ஸ்கிரிப்டை வெளியிட்டுள்ளது. நிறுவனம் $466 மில்லியன் நெட் நியூ TCV வெற்றிகளையும், $1.8 பில்லியன் டிரெய்லிங் ட்வெல்வ்-மன்த் (TTM) TCV-யையும் அறிவித்துள்ளது. ஒட்டுமொத்த ஒப்பந்தப் பட்டியல் 23% YoY மற்றும் 4.4% காலாண்டு வரிசையில் அதிகரித்து சாதனை அளவை எட்டியதால், நிறுவனம் ஆண்டு வளர்ச்சி முன்னறிவிப்பை உயர்த்தியுள்ளது. காலாண்டு TCV வெற்றிகளில் 66%-ம், மொத்த ஒப்பந்தப் பட்டியலில் 71%-ம் Mphasis Tria தளத்தால் இயக்கப்படும் AI சார்ந்த ஒப்பந்தங்கள் என நிர்வாகம் சுட்டிக்காட்டியுள்ளது. இயக்கப் பணப்புழக்கத்தில் தற்காலிக ஏற்ற இறக்கம் ஏற்பட்டுள்ளது. காலாண்டு இறுதியைத் தாண்டி $39 மில்லியன் வசூல் நேரச் சறுக்கல் இதில் அடங்கும். பணப்புழக்க மாற்றம் FY28க்குள் இயல்பு நிலைக்கு வரும் என நிர்வாகம் எதிர்பார்க்கிறது.
உச்சம் நம்பிக்கை
என்ன மாறியதுநவம்பர் 6, 2026 அன்று நடைபெற்ற Q2 FY27 நிதி முடிவுகள் கான்பரன்ஸ் கால் பற்றிய முறையான டிரான்ஸ்கிரிப்ட் சமர்ப்பிக்கப்பட்டது.
ஏன் இது முக்கியம்உயர்த்தப்பட்ட முழு ஆண்டு வளர்ச்சி முன்னறிவிப்பு, நிறுவன AI தளமான Tria-வின் விரிவாக்கம், சமீபத்திய பணப்புழக்க மாற்றத்துக்கான விளக்கங்கள் ஆகியவை பற்றிய விரிவான தரமான கருத்துகளை இது வழங்குகிறது.
Net new TCV (Q2): $466 மில்லியன்டிரெய்லிங் 12-மாத TCV: $1.8 பில்லியன்TCV வெற்றிகளில் AI சார்ந்த பங்கு: 66%மொத்த பட்டியல் YoY வளர்ச்சி: 23%பணப்புழக்க நேரச் சறுக்கல்: $39 மில்லியன்
📅 குறுகிய காலம்கான்கால் உயர்த்தப்பட்ட வளர்ச்சி முன்னறிவிப்பையும் ஆரோக்கியமான ஒப்பந்த வருகையையும் உறுதிப்படுத்துவதால் நடுநிலையிலிருந்து சற்று சாதகமானது. ஆயினும் இந்த விவரங்கள் பெரும்பாலும் முடிவுகள் அறிவிப்பிலேயே தெரிவிக்கப்பட்டுவிட்டன.
📈 நீண்ட காலம்Mphasis Tria வாடிக்கையாளர்களின் பட்ஜெட்களை செயல்பாடு மற்றும் வணிக மாற்றத்துக்கு விரிவுபடுத்தினால் கட்டமைப்பு ரீதியில் சாதகமானது. FY28 வரை பணப்புழக்க மாற்றம் கண்காணிக்க வேண்டிய முக்கிய அளவீடாக உள்ளது.
⚠ அபாய எச்சரிக்கைகள்
முன்கூட்டிய ஒப்பந்த முதலீடுகளால் மொத்த வருவாய் வளர்ச்சிக்கும் இயக்கப் பணப்புழக்க (OCF) மாற்றத்துக்கும் இடையிலான இணைப்பு விலகியிருப்பது
அமெரிக்க விருப்பச் செலவு மற்றும் வங்கி/அடமானச் செலவுப் போக்குகளைச் சார்ந்திருத்தல்
👀 கவனிக்க வேண்டியவை
காலாண்டு $466 மில்லியன் TCV, H2 FY27 காலத்தில் அறிக்கையிடப்பட்ட வருவாயாக எவ்வாறு மாறுகிறது என்பதைக் கண்காணியுங்கள். நிர்வாகம் முன்னறிவித்த இயல்புநிலை FY28க்குள் வருகிறதா என்பதைச் சரிபார்க்க இயக்கப் பணப்புழக்க மீட்சியையும் கவனியுங்கள்.
Apsis Aerocom H1 FY27 Revenue Up 55% YoY to ₹21.17 Cr; Net Profit at ₹3.97 Cr
Apsis Aerocom reported financial results for the half year ended September 30, 2026, with revenue from operations growing 55.1% YoY to ₹2,117.26 lakhs compared to ₹1,365.12 lakhs in H1 FY26. Net profit rose 21.4% YoY to ₹396.74 lakhs from ₹326.73 lakhs, though it contracted compared to H2 FY26 profit of ₹424.33 lakhs. Basic EPS stood at ₹3.29 for the half year. Additionally, the company reported utilizing ₹2,557.15 lakhs of the ₹3,577.20 lakhs gross IPO proceeds, primarily deploying ₹1,951.71 lakhs toward machinery capex.
உச்சம் நம்பிக்கை
என்ன மாறியதுApsis Aerocom declared its half-yearly financial results for H1 FY27 along with an update on IPO fund deployment showing no deviations.
ஏன் இது முக்கியம்Demonstrates rapid revenue expansion alongside execution of planned capex, as gross fixed assets doubled post-IPO proceeds deployment.
Revenue from Operations (H1 FY27): ₹2,117.26 லட்சம்Net Profit (H1 FY27): ₹396.74 லட்சம்Basic EPS (H1 FY27): ₹3.29Machinery Capex Utilised from IPO: ₹1,951.71 லட்சம்Property, Plant and Equipment: ₹2,461.31 லட்சம்
📅 குறுகிய காலம்Positive reaction expected given strong top-line YoY expansion and visible deployment of IPO proceeds into tangible assets.
📈 நீண்ட காலம்Significant addition to Property, Plant and Equipment suggests capacity ramp-up that could support long-term revenue growth, though margin sustainability remains key.
⚠ அபாய எச்சரிக்கைகள்
Sequential net profit decline relative to H2 FY26 (₹396.74 lakhs vs ₹424.33 lakhs) despite revenue increase
₹1,020.05 lakhs in unutilized IPO proceeds still pending deployment
👀 கவனிக்க வேண்டியவை
Track operational utilization of the newly acquired machinery (reflected in capex additions) and monitor whether second-half top-line growth maintains momentum without further compression in operating margins.
Medi Assist H1 FY27 Net Profit Jumps 60.2% to ₹49.2 Cr; Board Clears ₹49.3 Cr Share Buyback
Medi Assist Healthcare Services released its Q2 & H1 FY27 earnings call transcript, highlighting that consolidated H1 income grew 13.8% YoY to ₹492.4 crore and PAT jumped 60.2% YoY to ₹49.2 crore. Operating margins improved with consolidated H1 EBITDA rising 19% to ₹97.2 crore (20.3% margin) as the Paramount acquisition integration was completed. The company announced a share buyback of ₹49.3 crore at ₹425 per share (representing ~1.6% of market cap). Management indicated that group client retention dropped to 90.5% due to Paramount portfolio churn, but expects it to return to 93-94% over the next 3-4 quarters.
உச்சம் நம்பிக்கை
என்ன மாறியதுFormal disclosure of detailed management commentary via earnings call transcript following Q2 & H1 FY27 results, including capital allocation framework and buyback details.
ஏன் இது முக்கியம்Confirms the full operational integration of Paramount onto the MAtrix platform and establishes a policy of returning ~50% of cumulative adjusted free cash flow over rolling 5-year periods.
H1 FY27 Consolidated Revenue: ₹492.4 கோடிH1 FY27 Reported PAT: ₹49.2 கோடிBuyback size: ₹49.3 கோடிBuyback price per share: ₹425Buyback vs Market Cap: ~1.64%Group business retention rate: 90.5%
📅 குறுகிய காலம்The completion of the Paramount integration and announcement of the ₹425/share buyback provide positive sentiment support, though the filing is a post-earnings transcript.
📈 நீண்ட காலம்Monetization of the SaaS/platform bundles and expansion of international claims processing represent margin-accretive growth levers beyond traditional TPA business.
⚠ அபாய எச்சரிக்கைகள்
Depressed client retention rate at 90.5% due to acquired portfolio churn, expected to persist for 2-3 quarters.
Dependence on annual insurance contract renewals for the mainstay group TPA division.
👀 கவனிக்க வேண்டியவை
Track the execution and timeline of the announced ₹49.3 crore buyback and monitor group retention metrics over the next 2-3 quarters to confirm the projected recovery to 93-94%.
Mphasis Q2 FY27 Results: Net Profit Up 19.6% YoY to ₹561.1 Cr, Revenue Grows 17.4% to ₹4,580.9 Cr
Mphasis reported its consolidated financial results for the quarter ended September 30, 2026, posting revenue from operations of ₹4,580.93 crore, up 17.4% YoY from ₹3,901.91 crore and 4.5% QoQ from ₹4,384.05 crore. Profit for the period grew 19.6% YoY to ₹561.13 crore compared to ₹469.07 crore in Q2 FY26 (up 14.6% QoQ from ₹489.51 crore). Diluted EPS for the quarter stood at ₹29.34 compared to ₹24.54 in the prior-year quarter. Growth was anchored by Banking and Financial Services, which delivered segment revenue of ₹2,474.04 crore, up 22.7% YoY.
உச்சம் நம்பிக்கை
என்ன மாறியதுApproval and release of audited Q2 and H1 FY27 standalone and consolidated financial results.
ஏன் இது முக்கியம்Demonstrates consistent double-digit revenue and PAT expansion led by the core BFSI vertical despite broader IT sector macroeconomic headwinds.
Q2 FY27 Revenue from operations: ₹4,580.93 கோடிQ2 FY27 Net Profit: ₹561.13 கோடிQ2 FY27 Diluted EPS: ₹29.34BFSI Segment Revenue: ₹2,474.04 கோடிH1 FY27 Revenue: ₹8,964.98 கோடி
📅 குறுகிய காலம்Earnings beat or in-line performance with sequential margin improvement should support stock sentiment in the near term.
📈 நீண்ட காலம்Sustained execution in AI-led solutions and high exposure to large banking clients position the firm to capture revival in enterprise technology budgets.
⚠ அபாய எச்சரிக்கைகள்
High geographic and client dependency on US BFSI and mortgage segments
Talent cost pressures and potential volatility in hedge-related adjustments
👀 கவனிக்க வேண்டியவை
Track management commentary on US BFSI discretionary spending and deal ramp-ups in subsequent quarters, alongside TCV deal win momentum.
Mphasis released its investor presentation for Q2 FY27, reporting quarterly gross revenue of $486 million, up 3.3% QoQ and 14.6% YoY. Operating margin stood steady at 14.8%, while quarterly EPS reached Rs 29.4 (up 14.8% from Q1 FY27). Net new TCV wins for the quarter were $466 million, with 66% being AI-led, bringing the trailing twelve-month (TTM) TCV to $1.8 billion. The company maintained its FY27 guidance of low double-digit constant-currency revenue growth and an operating margin band of 14.75% to 15.75%.
உச்சம் நம்பிக்கை
என்ன மாறியதுRelease of the detailed Q2 FY27 financial performance presentation alongside reaffirmation of full-year growth and margin targets.
ஏன் இது முக்கியம்Provides granularity on deal wins ($466M TCV) and increasing AI adoption (66% of wins, 71% of pipeline), which underpins future revenue visibility.
📅 குறுகிய காலம்Stable operating margins (14.8%) and healthy sequential growth in BFS Direct (4.5% QoQ) will likely support sentiment in the upcoming trading sessions.
📈 நீண்ட காலம்Rising proportion of AI-led deals (66% of TCV) and expanding pipeline offer structural support toward achieving the company's low double-digit growth trajectory.
⚠ அபாய எச்சரிக்கைகள்
DSO elongation to 113 days (normalized 105 days vs 89 days in Q2 FY26)
Significant dependence on US macro environment and BFS client spend
👀 கவனிக்க வேண்டியவை
Track the conversion rate of the $9,256 million pipeline into reported revenue and monitor if operating margins hold in the stated 14.75%-15.75% target band in H2 FY27.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Persistent Systems Allots ₹600 Cr Commercial Papers at 8.75% Yield
Persistent Systems has allotted 12,000 Commercial Papers (CPs) aggregating to ₹600 crore (INR 6.00 billion) on November 5, 2026. The CPs have a face value of ₹5,00,000 each and were issued at ₹459,770 per security with a tenure of 1 year maturing on November 5, 2027. The yield and discount rate for the issuance is fixed at 8.75%. Compared to the company's existing debt of ₹499 crore and net worth of ₹7,471 crore, this short-term borrowing represents approximately 8.0% of net worth and will be listed on the National Stock Exchange.
உச்சம் நம்பிக்கை
என்ன மாறியதுPersistent Systems completed the issuance and allotment of ₹600 crore worth of 1-year Commercial Papers.
ஏன் இது முக்கியம்Provides ₹600 crore of short-term liquidity at an 8.75% cost of capital, temporarily increasing the company's debt profile relative to its existing ₹499 crore debt.
வெளியீட்டு அளவு: INR 6.00 billionYield / Discount rate: 8.75%Tenure: 1 (One) yearIssue size vs Net Worth: ~8.03%Issue size vs TTM Revenue: ~3.82%
📅 குறுகிய காலம்Neutral for the stock as this is a standard treasury funding mechanism, though it increases short-term finance costs.
📈 நீண்ட காலம்Limited structural impact given the 1-year tenure and the company's robust balance sheet with low overall leverage.
⚠ அபாய எச்சரிக்கைகள்
Increase in short-term interest obligations at an 8.75% borrowing rate
👀 கவனிக்க வேண்டியவை
Monitor upcoming quarterly disclosures for the deployment of these short-term funds, such as working capital management or funding prospective tuck-in acquisitions.
SIS Q2 PAT Rises 37.1% YoY to ₹110.7 Cr; Revenue Up 28.1% to ₹4,816 Cr
SIS Limited reported a strong Q2 FY27 performance, with consolidated revenue rising 28.1% YoY to ₹4,816.0 Cr and highest-ever quarterly PAT increasing 37.1% YoY to ₹110.7 Cr. EBITDA rose 32.7% YoY to ₹223.3 Cr with margins improving slightly to 4.6%. Growth was led by Security Solutions India, which jumped 38.9% YoY to ₹2,144.1 Cr. However, cash flow generation showed strain, with OCF/EBITDA at -44.4% and Net Debt/EBITDA rising to 1.24x.
உச்சம் நம்பிக்கை
என்ன மாறியதுSIS reported its Q2 FY27 financial results, marking all-time high quarterly revenue of ₹4,816 Cr and quarterly PAT of ₹111 Cr.
ஏன் இது முக்கியம்Demonstrates robust top-line acceleration and margin resilience across domestic and international security segments, though accompanied by working capital headwinds.
📅 குறுகிய காலம்Strong operational beat on revenue and net profit will likely support market sentiment, offset somewhat by negative operating cash conversion.
📈 நீண்ட காலம்Continued market share gains in organized security and facility management, combined with potential Labour Code repricing, provide multi-year revenue visibility.
⚠ அபாய எச்சரிக்கைகள்
Negative operating cash flow (OCF/EBITDA at -44.4%) in the quarter
Leverage ticked up with Net Debt/EBITDA rising from 1.05x in June 2026 to 1.24x
High structural employee attrition risks in the security services industry
👀 கவனிக்க வேண்டியவை
Track cash flow turnaround and working capital improvement in subsequent quarters, alongside upcoming contract repricing from the anticipated Labour Code rollout.
Persistent Systems Allots ₹7,000 Cr NCDs to Finance Nagarro SE Acquisition
Persistent Systems has approved the allotment of 700,000 senior, rated, listed redeemable Non-Convertible Debentures (NCDs) aggregating to ₹7,000 crore (INR 70 billion) on a private placement basis. The issuance spans multiple series, including Series 1 and Series 2 at an 8.95% coupon rate with 2-year and 3-year tenors, respectively. The security terms explicitly reveal that proceeds are tied to the acquisition/merger of Nagarro SE via Galaxy Germany Holding SE. This represents a massive leverage expansion for Persistent Systems, whose pre-issue debt was just ₹499 crore against a net worth of ₹7,471 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுPersistent Systems approved the private placement allotment of ₹7,000 crore in NCDs across multiple tranches maturing between 2028 and 2031.
ஏன் இது முக்கியம்The fundraise marks a transformative, highly leveraged M&A transaction targeting Nagarro SE, radically altering Persistent's balance sheet from virtually zero debt to significant leverage.
Total NCD Issue Size: ₹7,000 crore (INR 70 billion)Issue Size vs Net Worth: ~93.7%Issue Size vs TTM Revenue: ~44.5%Series 1 & 2 Coupon Rate: 8.95% per annumAllotment Date: 4 நவம்பர் 2026
📅 குறுகிய காலம்Markets are likely to react to the surprise scale of debt issuance and examine the implied interest burden (over ₹600 crore annually) relative to TTM PAT of ₹1,923 crore.
📈 நீண்ட காலம்If successfully merged, acquiring Nagarro SE could materially scale Persistent's global delivery and European presence, but integration execution and debt servicing will be pivotal determinants of long-term returns.
⚠ அபாய எச்சரிக்கைகள்
Sharp increase in leverage: total debt increases from ₹499 crore to ~₹7,500 crore
M&A execution and integration risk relating to European-listed Nagarro SE
Substantial annual interest cost burden impacting net margins
👀 கவனிக்க வேண்டியவை
Track subsequent disclosures on the acquisition terms, valuation, and integration timeline of Nagarro SE, as well as the impact of higher interest costs (~8.95% on ₹7,000 crore) on quarterly profitability.
Medi Assist Announces ₹49.27 Cr Share Buyback at ₹425 via Tender Offer
Medi Assist Healthcare Services has released its public announcement and board resolution for a share buyback of up to 11,59,199 equity shares at ₹425 per share via tender offer. The aggregate buyback size is up to ₹49.27 crore, representing 1.55% of total paid-up equity shares and 5.97% of consolidated net worth. The offer price represents a significant premium over recent market prices, including a 47% premium over the closing price of ~₹289. The record date is set for November 20, 2026, and promoter group members will not participate.
உச்சம் நம்பிக்கை
என்ன மாறியதுFormal intimation of the public announcement and certified board resolution confirming the ₹49.27 crore tender-offer buyback schedule and terms.
ஏன் இது முக்கியம்The buyback returns excess cash to shareholders at a premium to prevailing market prices (~₹289) and marginally improves EPS/ROE post-extinguishment of ~1.55% equity capital.
Buyback Price: ₹ 425/- per equity shareTotal Buyback Size: ₹ 49,26,59,575/-Number of Shares to Buy Back: 11,59,199Share of Equity Capital: 1.55%ரெக்கார்ட் தேதி: நவம்பர் 20, 2026Buyback Size vs Market Cap: ~1.61%
📅 குறுகிய காலம்The substantial premium over market price offers an arbitrage/tendering opportunity, especially for retail shareholders with the mandated 15% reservation.
📈 நீண்ட காலம்Limited operational impact as the size represents ~1.55% of equity, but it signals disciplined capital allocation and cash generation.
⚠ அபாய எச்சரிக்கைகள்
Acceptance ratio uncertainty depending on total retail tendering participation
Small overall buyback size relative to total market capitalization (~1.6%)
👀 கவனிக்க வேண்டியவை
Investors should note the record date of November 20, 2026, to determine eligibility for the tender offer, and watch for the subsequent dispatch of the Letter of Offer and opening of the tendering window.
Medi Assist H1 FY27: EBITDA Up 19% to ₹97.2 Cr, Margin at 20.3%; ₹49.3 Cr Buyback Approved
Medi Assist reported strong H1 FY27 operating performance with revenue rising 13.0% YoY to ₹478.0 Cr and operating EBITDA growing 19.0% YoY to ₹97.2 Cr. EBITDA margins expanded by 103 bps to 20.3%, supported by the complete integration of Paramount and operating leverage from technology monetization. Profit After Tax rose 59.5% YoY, and group health market share expanded to 34.1%. Additionally, the Board approved a share buyback of up to ~₹49.3 Cr (~1.6% of current market cap) funded via internal cash flows.
உச்சம் நம்பிக்கை
என்ன மாறியதுParamount integration is complete, bringing margin expansion back above 20%, and the Board has initiated a ₹49.3 Cr capital return via share buyback.
ஏன் இது முக்கியம்Demonstrates operating leverage as integration headwinds ease and high-margin SaaS revenue (+83.8% YoY) begins contributing more significantly to the bottom line.
H1 FY27 Revenue: ₹478.0 கோடிH1 FY27 EBITDA: ₹97.2 கோடிEBITDA லாப வரம்பு: 20.3%Approved Buyback Size: ₹49.3 கோடிBuyback vs Market Cap: ~1.6%Cash and Cash Equivalents: ₹268.3 கோடி
📅 குறுகிய காலம்Likely positive reaction driven by margin expansion crossing the 20% mark, strong PAT growth (+59.5%), and the capital allocation signal from the buyback announcement.
Execution timeline risks for remaining 4 insurer SaaS integrations in H2 FY27
👀 கவனிக்க வேண்டியவை
Track the full buyback schedule and pricing details once disclosed, and monitor the go-live of the remaining four contracted insurers on the SaaS stack scheduled for H2 FY27.
Medi Assist Q2FY27 PAT Jumps 167.5% YoY to ₹21.6 Cr; EBITDA Margin Expands to 20.4%
Medi Assist released its Q2 and H1FY27 investor presentation following the complete integration of Paramount Health Services. Consolidated Q2FY27 operating revenue grew 3.9% YoY to ₹241.5 Cr, while EBITDA rose 23.9% YoY to ₹49.2 Cr, expanding EBITDA margin by 331 bps to 20.4%. Reported PAT surged 167.5% YoY to ₹21.6 Cr in Q2FY27, driven by operating leverage and reduced integration costs. For H1FY27, operating revenue reached ₹478.0 Cr (+13.0% YoY) with an EBITDA margin of 20.3% and zero debt.
உச்சம் நம்பிக்கை
என்ன மாறியதுParamount integration is 100% complete, enabling post-acquisition margin recovery and a shift toward higher-margin SaaS/platform solutions.
ஏன் இது முக்கியம்Demonstrates operating leverage as integration headwinds recede, lifting EBITDA margins back above 20% while expanding group TPA market share to 34.1%.
Q2FY27 Operating Revenue: ₹241.5 கோடிQ2FY27 EBITDA Margin: 20.4%Q2FY27 Reported PAT: ₹21.6 கோடிH1FY27 Total Income: ₹492.4 கோடிCash and Cash Equivalents: ₹268.3 கோடி
📅 குறுகிய காலம்Market sentiment should react positively to the strong margin expansion (+331 bps) and confirmation of completed integration costs.
📈 நீண்ட காலம்Scalability depends on increasing high-margin SaaS/platform adoption (currently ~4-5% of revenue) and defending its ~34% market share in Group TPA.
⚠ அபாய எச்சரிக்கைகள்
Low promoter holding at 4.61%
Tail-end client churn risk following acquisition integration expected over next 2-3 quarters
Dependency on annual contract renewals with health insurers
👀 கவனிக்க வேண்டியவை
Track margin progression toward the historical 22-23% target as Paramount synergies materialize, alongside client retention rates over the next 3-4 quarters.
Medi Assist Approves ₹49.27 Cr Share Buyback at ₹425/share via Tender Offer; Record Date Nov 20
Medi Assist Healthcare Services has approved a share buyback of up to 11,59,199 equity shares at ₹425 per share, aggregating up to ₹49.27 crore via the tender offer route. The buyback price of ₹425 represents an approximate 44% premium over the current market price of ₹295.20. The buyback covers up to 1.55% of total paid-up equity share capital, with promoters (holding 4.61%) opting not to participate. The company has fixed Friday, November 20, 2026, as the record date for determining shareholder eligibility.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board approved a ₹49.27 crore tender offer buyback at ₹425 per share and set the record date for November 20, 2026.
ஏன் இது முக்கியம்The buyback represents approximately 1.58% of the company's ₹3,122 crore market cap and distributes surplus cash to public shareholders at a substantial premium, slightly boosting EPS post-extinguishment.
Buyback Price: INR 425/- per Equity ShareBuyback Size: INR 49,26,59,575/-Shares to be bought back: 11,59,199Equity Capital %: 1.55%Buyback vs Market Cap: ~1.58%ரெக்கார்ட் தேதி: நவம்பர் 20, 2026
📅 குறுகிய காலம்The significant premium to the market price (₹425 vs ₹295.20) may generate trading interest and provide downside support leading up to the November 20, 2026 record date.
📈 நீண்ட காலம்Limited; at 1.55% of equity, the reduction in share count will offer a modest accretion to future EPS and ROCE, but does not alter core operating trajectory.
⚠ அபாய எச்சரிக்கைகள்
Tender offer acceptance ratio will depend on overall retail participation, limiting the number of shares that can be successfully tendered at ₹425
👀 கவனிக்க வேண்டியவை
Track the dispatch of the Letter of Offer and public announcement for exact tender timelines, as well as the entitlement ratio for retail shareholders on the Record Date (November 20, 2026).
Persistent Systems raises ₹4,264.6 Cr via QIP at ₹5,550 per share
Persistent Systems has approved the allotment of 7,683,981 equity shares to Qualified Institutional Buyers at an issue price of ₹5,550.00 per share, raising approximately ₹4,264.61 crore. The issue price reflects a 3.66% discount (₹211 per share) to the floor price. Post-allotment, the company's total paid-up equity shares expanded from 158,150,000 to 165,833,981, representing an equity dilution of approximately 4.63%. Major institutional allottees include mutual funds managed by SBI, ICICI Prudential, Kotak, and Aditya Birla Sun Life, alongside Government Pension Fund Global.
உச்சம் நம்பிக்கை
என்ன மாறியதுPersistent Systems closed its QIP, issuing 7,683,981 new equity shares and raising ₹4,264.61 crore in fresh equity capital.
ஏன் இது முக்கியம்The fundraise expands the company's cash reserves significantly (amounting to ~57% of existing net worth), providing strong dry powder for large acquisitions and strategic growth initiatives.
Total fundraise: INR 42,646.09 millionFundraise vs Net Worth: ~57.1%Issue price per share: INR 5,550.00Equity dilution: ~4.63%Discount to floor price: 3.66%
📅 குறுகிய காலம்Short-term equity supply increases as 7.68 million new shares are listed; however, strong institutional demand and modest discount (3.66%) reflect institutional confidence.
📈 நீண்ட காலம்Substantially bolsters cash balances to pursue inorganic acquisitions and accelerate the company's target run rate toward $2 billion in revenue.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of ~4.63% to existing shareholders
Deployment risk regarding whether the newly raised capital achieves targeted ROCE levels
👀 கவனிக்க வேண்டியவை
Track subsequent company disclosures regarding the deployment of the ₹4,264.61 crore proceeds, particularly whether capital is utilized for strategic tuck-in M&A or balance sheet strengthening.
Persistent Systems Closes QIP to Raise ~₹4,265 Cr via 76.84 Lakh Shares at ₹5,550/Share
Persistent Systems has officially closed its Qualified Institutional Placement (QIP) on October 26, 2026. The company approved the allocation of 7,683,981 equity shares at an issue price of ₹5,550.00 per share, which represents a 3.66% discount (₹211 per share) to the floor price of ₹5,761.00. The fundraise totals approximately ₹4,264.6 crore, representing roughly 4.7% of the company's current market capitalization of ₹91,540 crore and over 57% of its existing net worth. The placement document was formally adopted and allocation notices are being issued.
உச்சம் நம்பிக்கை
என்ன மாறியதுPersistent Systems has formally closed its QIP, pricing and allocating 7,683,981 shares at ₹5,550 each to institutional investors.
ஏன் இது முக்கியம்The infusion of ~₹4,265 crore significantly bolsters the balance sheet, expanding cash reserves for strategic acquisitions and scaling towards its $2 billion revenue run-rate target, with minor equity dilution of ~4.9%.
Shares allocated: 7,683,981வெளியீட்டு விலை: ₹5,550.00 per shareDiscount to floor price: 3.66% (₹211.00)Floor price: ₹5,761.00 per shareTotal raise vs Market Cap: ~4.7%Total raise vs Net Worth: ~57.1%
📅 குறுகிய காலம்Short-term impact includes absorption of the new equity supply (~4.9% dilution of share capital) and trading settlement around the issue price of ₹5,550.
📈 நீண்ட காலம்Strengthens capital reserves substantially to fund targeted tuck-in acquisitions, scale core verticals (BFSI and HLS), and invest in proprietary platforms like SASVA AI.
⚠ அபாய எச்சரிக்கைகள்
Dilution of existing equity holders (~4.9%)
Reinvestment/M&A integration execution risk
👀 கவனிக்க வேண்டியவை
Track the upcoming equity allotment filing, listing of the newly issued shares on exchanges, and management commentary on capital deployment plans (such as tuck-in M&A or AI capabilities).
Persistent Systems released its Q2 FY27 earnings call transcript, reporting USD 487.6 million in revenue, up 7.8% QoQ and 20% YoY in USD terms (8.4% QoQ and 30.3% YoY in INR). Total contract value (TCV) stood strong at USD 633.5 million, with new bookings contributing USD 367.1 million. EBIT margin was reported at 15%, while reported PAT margin came in at 7.5% after a 3.1% one-time impact from exceptional Nagarro acquisition expenses. Management highlighted progress on integrating Nagarro to create an AI-led engineering firm targeting over $2.9 billion in revenue run rate.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript for the Q2 FY27 earnings conference call held on October 15, 2026.
ஏன் இது முக்கியம்Gives comprehensive detail on deal booking momentum (USD 633.5M TCV), margins, one-off Nagarro acquisition costs, and AI IP development investments.
📅 குறுகிய காலம்Neutral; the filing is a post-earnings call transcript and contains no unexpected new material disclosures beyond the October 15 call.
📈 நீண்ட காலம்The planned combination with Nagarro and expanding AI offerings like SASVA support long-term scaling towards a $3B+ run-rate, though margin integration remains key.
⚠ அபாய எச்சரிக்கைகள்
Exceptional M&A costs impacting near-term reported net margins
Europe revenue declined 8.5% YoY due to two client-specific contract completions/ramp-downs
👀 கவனிக்க வேண்டியவை
Track the closing and integration milestones of the Nagarro transaction, alongside recovery in the Healthcare and Life Sciences vertical in coming quarters.
ICRA Rates Persistent's Proposed Rs 7,000 Cr NCDs and Rs 1,000 Cr CP on Negative Watch
ICRA has assigned and continued ratings for Persistent Systems' proposed borrowing programs totaling Rs 8,000 crore. The agency continued the Issuer Rating and rating for Rs 5,000 crore of proposed NCDs at [ICRA]AA+ on Rating Watch with Negative Implications, while assigning [ICRA]AA+ (Rating Watch with Negative Implications) to an additional Rs 2,000 crore proposed NCDs. Additionally, ICRA assigned an [ICRA]A1+ rating to a proposed Rs 1,000 crore Commercial Paper program. The planned Rs 7,000 crore long-term NCD program is substantial relative to Persistent's existing debt of Rs 499 crore and net worth of Rs 7,471 crore (~93.7% of net worth), pointing to potential large-scale capital deployment or M&A.
உச்சம் நம்பிக்கை
என்ன மாறியதுICRA assigned ratings to fresh proposed borrowings (Rs 2,000 crore NCDs and Rs 1,000 crore CP) while maintaining the issuer and NCD ratings under Rating Watch with Negative Implications.
ஏன் இது முக்கியம்A potential debt raise of up to Rs 7,000-8,000 crore would significantly reshape Persistent's balance sheet, increasing leverage against its current low debt base of Rs 499 crore.
Total Proposed NCDs: Rs 7,000.00 croreProposed Commercial Paper: Rs 1,000.00 croreProposed NCDs vs Net Worth: ~93.7%Current Existing Debt: Rs 499 crore
📅 குறுகிய காலம்Markets will monitor disclosures regarding the deployment plans for the Rs 7,000 crore proposed debt program and any commentary on the reasons for the Rating Watch.
📈 நீண்ட காலம்If fully tapped for growth or M&A, the substantial debt program will increase financial leverage and interest costs, altering Persistent's historically net-cash profile.
⚠ அபாய எச்சரிக்கைகள்
Rating Watch with Negative Implications indicates potential downgrade risk.
Potential sharp increase in leverage if Rs 7,000 crore NCDs are fully issued (nearly doubling total liabilities relative to net worth).
👀 கவனிக்க வேண்டியவை
Track the company's announcements regarding the purpose of this large debt raise (e.g., potential sizeable M&A) and ICRA's resolution of the Rating Watch with Negative Implications.
Persistent Systems Assigned 'CRISIL AA+' on Proposed NCDs; Placed on Watch with Developing Implications
Persistent Systems has received a credit rating of 'CRISIL AA+' from CRISIL Ratings Limited for its proposed Non-Convertible Debentures (NCDs). The rating has been placed on 'Rating Watch with Developing Implications'. The total quantum and issue timeline of the proposed NCD borrowing were not disclosed in the filing. This indicates potential debt fundraising, in contrast to the company's existing low debt profile of ₹499 crore (D/E of 0.07).
உச்சம் நம்பிக்கை
என்ன மாறியதுCRISIL Ratings assigned a 'CRISIL AA+' rating with developing implications to Persistent Systems' proposed NCDs.
ஏன் இது முக்கியம்Indicates an impending debt capital raise, which could be utilized for organic expansion or tuck-in M&A given the company's low leverage (0.07 D/E).
Credit rating: CRISIL AA+Rating outlook: Rating Watch with Developing ImplicationsCurrent total debt: ₹499 கோடிDebt to Equity ratio: 0.07
📅 குறுகிய காலம்Neutral to cautious as the market awaits specifics on the issue size and reason behind the 'Developing Implications' watch.
📈 நீண்ட காலம்Limited operational impact until debt proceeds and intended capital allocation (e.g., M&A or capex) are formally announced.
⚠ அபாய எச்சரிக்கைகள்
Uncertainty around the 'Developing Implications' tag which may reflect pending corporate actions or M&A
Potential increase in leverage depending on issue size
👀 கவனிக்க வேண்டியவை
Track subsequent filings detailing the exact quantum, coupon, and end-use of the proposed NCD issue, as well as CRISIL's eventual resolution of the 'Rating Watch with Developing Implications'.
Persistent Systems Sets Issue Floor Price at ₹5,761 Per Share for Capital Raise
Persistent Systems Limited announced that its Special Committee of the Board has fixed a floor price of ₹5,761.00 per equity share for its proposed issue under SEBI ICDR Regulations. The floor price stands at a modest ~1.7% discount to the prevailing market price of ₹5,858.50. This confirms the pricing formula benchmark for an upcoming equity fundraise, though total issue size was not detailed in this update.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Special Committee formally confirmed and taken on record the statutory SEBI ICDR floor price of ₹5,761.00 per share for the planned equity issue.
ஏன் இது முக்கியம்Determines the baseline valuation for institutional/qualified investors, setting the stage for equity dilution to fund strategic growth or tuck-in acquisitions.
Issue Floor Price: INR 5,761.00 per Equity ShareCurrent Market Price: Rs 5858.5Floor Price Discount to CMP: ~1.7%
📅 குறுகிய காலம்Short-term stock movement will likely track the final issue pricing and potential discount offered relative to the ₹5,761 floor price.
📈 நீண்ட காலம்Capital raised could strengthen the balance sheet for targeted tuck-in acquisitions to accelerate progress toward the company's $2 billion revenue target.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution for existing shareholders
Deployment risk depending on target acquisition valuations and integration
👀 கவனிக்க வேண்டியவை
Track subsequent disclosures regarding the final issue price, total dilution/shares being issued, and the intended deployment of raised proceeds (e.g., M&A or debt reduction).
Persistent Launches ₹4,264.6 Cr ($450M) QIP at Floor Price of ₹5,550/share
Persistent Systems has approved the opening of a Qualified Institutions Placement (QIP) on October 21, 2026, to raise up to $450 million (approx. ₹4,264.61 crore). The Special Committee set the floor price at ₹5,550 per equity share, which is a ~5.3% discount to the current market price of ₹5,858.5. The company may also offer an additional discount of up to 5% on the floor price as per SEBI regulations. The issue represents approximately 4.6% of the company's current market cap of ₹91,673 crore and ~57% of its current net worth.
உச்சம் நம்பிக்கை
என்ன மாறியதுPersistent has formally opened its institutional fundraise (QIP) of up to $450 million with a set floor price of ₹5,550 per share.
ஏன் இது முக்கியம்The fundraise injects significant growth capital (~57% of net worth) to pursue tuck-in acquisitions and target its $2 billion revenue run rate, but will dilute existing equity by around 4-5%.
Issue Size: INR 42,646.10 millionFloor Price: INR 5,550 per Equity ShareIssue Size vs Market Cap: ~4.65%Issue Size vs Net Worth: ~57.1%RBI/FBIL Reference Rate: INR 94.7691 per USD
📅 குறுகிய காலம்Short-term stock movement may see mild pressure or consolidation near the issue price, which is at a discount to the recent market price of ₹5,858.5.
📈 நீண்ட காலம்Provides substantial dry powder to fund inorganic expansion (tuck-in acquisitions), expand SASVA AI offerings, and support the trajectory towards a $2 billion revenue run-rate.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of roughly 4.5% to 5.0% for existing shareholders
Deployment/reinvestment risk if capital is not deployed accretively in acquisitions
👀 கவனிக்க வேண்டியவை
Track the final issue price and total equity dilution upon issue closure, along with management's specific deployment plans for the ₹4,265 crore proceeds (e.g., M&A pipeline or AI scaling).
SIS Limited has successfully closed its open-market share buyback on October 16, 2026. The company deployed ₹105.99 crore, representing 100.00% of the maximum buyback size, repurchasing 25,02,674 equity shares at a volume weighted average price of ₹423.55 per share. Total equity capital decreased from 14,13,07,643 shares to 13,88,49,242 shares (accounting for ESOP additions), lifting promoter shareholding from 71.86% to 73.13%.
உச்சம் நம்பிக்கை
என்ன மாறியதுSIS completed its open-market share repurchase program, exhausting the approved limit of ₹106 crore on October 16, 2026.
ஏன் இது முக்கியம்The buyback deployed ~1.9% of the company's current market capitalisation (₹5,649 Cr), reducing outstanding shares and delivering a modest EPS accretion for existing shareholders.
Total Amount Deployed: ₹ 105.99 CroresShares Repurchased: 25,02,674VWAP per Share: ₹ 423.55Buyback as % of Market Cap: ~1.88%Post-Buyback Promoter Stake: 73.13%
📅 குறுகிய காலம்Daily open-market purchasing support from the company will cease, leaving the stock to trade purely on regular market liquidity and quarterly operational updates.
📈 நீண்ட காலம்Limited; capital reduction slightly enhances EPS and RoE, but core business drivers remain workforce expansion and margin execution in security services.
👀 கவனிக்க வேண்டியவை
Track the upcoming release of the post-buyback public advertisement and the formal extinguishment of the final 3,28,540 equity shares.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
